Martin Dahl
Corporate Officer/Principal bij ANAPTYSBIO, INC.
Oorsprong van het eerstegraads netwerk van Martin Dahl
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 27 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Martin Dahl via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ALZA CORPORATION | Pharmaceuticals: Major | Sales & Marketing | |
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Chief Operating Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| LA JOLLA PHARMACEUTICAL COMPANY | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Private Equity Investor | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| SEAGEN INC. | Pharmaceuticals: Major | Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Director/Board Member | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Founder | |
| KYTHERA BIOPHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Calistoga Pharmaceuticals, Inc.
 Calistoga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Calistoga Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The company was founded by Michael W. Gallatin, Roger Ulrich and Neil Giese in March 2006 and is headquartered in Tumwater, WA. | Pharmaceuticals: Major | Chief Executive Officer Founder | |
Millendo Therapeutics US, Inc.
 Millendo Therapeutics US, Inc. Pharmaceuticals: MajorHealth Technology Millendo Therapeutics US, Inc. engages in the development of novel treatment for adrenal cancer. It focuses on developing a portfolio of disease-modifying treatments for endocrine disorders caused by hormone dysregulation. The company was founded by Raili E. Kerppola, Julia C. Owens, and Gary D. Hammer in January 2012 and is headquartered in Ann Arbor, MI. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Pennsylvania | College/University | Undergraduate Degree Graduate Degree | |
| AFFYMAX, INC. | Biotechnology | Chairman Chief Executive Officer | |
| FIBROGEN, INC. | Pharmaceuticals: Major | Chairman | |
| MIRATI THERAPEUTICS | Biotechnology | Director/Board Member Director of Finance/CFO | |
| San Diego State University | College/University | Undergraduate Degree Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Doctorate Degree Undergraduate Degree | |
| Kalamazoo College | College/University | Undergraduate Degree | |
| University of Western Ontario | College/University | Graduate Degree | |
| University of Arizona | College/University | Undergraduate Degree Graduate Degree | |
| University of Michigan | College/University | Masters Business Admin Undergraduate Degree | |
| University of San Diego | College/University | Undergraduate Degree Masters Business Admin | |
Cancer Care, Inc.
 Cancer Care, Inc. Hospital/Nursing ManagementHealth Services Cancer Care, Inc. provides cancer treatment services. The firm's services include counseling and support groups, education, financial assistance and practical help. The company was founded in 1944 and is headquartered in New York, NY. | Hospital/Nursing Management | Director/Board Member | |
Viron Therapeutics, Inc.
 Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| RELYPSA INC | Pharmaceuticals: Major | Chief Executive Officer | |
| Mercersburg Academy | College/University | Undergraduate Degree | |
| PFENEX INC. | Biotechnology | Director/Board Member Director/Board Member | |
Janssen Biotech, Inc.
 Janssen Biotech, Inc. Pharmaceuticals: MajorHealth Technology Janssen Biotech, Inc. engages in the development and marketing of prescription drugs. The company is headquartered in Horsham, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Rempex Pharmaceuticals, Inc.
 Rempex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rempex Pharmaceuticals, Inc. develops new therapies to combat the growing issue of antibiotic resistance. It focuses on the discovery and development of new antibacterial drugs to meet the clinical need created by multi-drug resistant bacterial pathogens. The company was founded by Daniel Burgess, Michael Dudley and Jeffery Loutit in June 2011 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Founder Director/Board Member | |
EcoR1 Capital, LLC
 EcoR1 Capital, LLC Investment ManagersFinance EcoR1 Capital LLC (EcoR1) is an independent registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded by Oleg Nodelman in 2012. EcoR1 serves as the general partner of and investment adviser to investment funds and provides investment advice to separate account clients. | Investment Managers | Chief Executive Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree | |
| Richard Ivey School of Business | College/University | Masters Business Admin | |
| SPARK THERAPEUTICS, INC. | Biotechnology | Public Communications Contact Corporate Officer/Principal | |
| SIENNA BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| XERIS BIOPHARMA HOLDINGS, INC. | Biotechnology | Director/Board Member | |
Trotana, Inc.
 Trotana, Inc. BiotechnologyHealth Technology Trotana, Inc. discovers and develops medicines. The company is based in San Diego, CA. The CEO of the company is Hamza Suria. | Biotechnology | Chief Executive Officer |
Statistieken
Internationaal
| Verenigde Staten | 46 |
| Canada | 4 |
| Japan | 2 |
Sectoraal
| Health Technology | 32 |
| Consumer Services | 12 |
| Finance | 4 |
| Commercial Services | 3 |
| Health Services | 2 |
Operationeel
| Director/Board Member | 180 |
| Independent Dir/Board Member | 71 |
| Corporate Officer/Principal | 66 |
| Undergraduate Degree | 27 |
| Director of Finance/CFO | 25 |
Sterkste connecties
| Insiders | |
|---|---|
| James Topper | 52 |
| Carol Gallagher | 39 |
| Magda Marquet | 30 |
| Dennis Fenton | 28 |
| John Schmid | 24 |
| John Orwin | 21 |
| Hollings Renton | 17 |
| Oleg Nodelman | 15 |
| Laura Hamill | 15 |
| Rita Jain | 14 |
| James Schoeneck | 12 |
| Eric Loumeau | 11 |
| Dennis Mulroy | 10 |
| Paul Lizzul | 10 |
| J. Ware | 9 |
- Beurs
- Insiders
- Martin Dahl
- Bedrijfsconnecties
